Universe Pharmaceuticals INC

NasdaqCM:UPC Voorraadrapport

Marktkapitalisatie: US$5.2m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Universe Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Universe Pharmaceuticals heeft een totaal eigen vermogen van $26.7M en een totale schuld van $6.5M, wat de schuld-eigenvermogensverhouding op 24.3% brengt. De totale activa en totale passiva bedragen respectievelijk $49.4M en $22.7M.

Belangrijke informatie

24.3%

Verhouding schuld/eigen vermogen

US$6.51m

Schuld

Rente dekkingsration/a
ContantUS$11.39m
AandelenUS$26.74m
Totaal verplichtingenUS$22.69m
Totaal activaUS$49.43m

Recente financiële gezondheidsupdates

Recent updates

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $33.5M ) UPC } overtreffen de korte termijn passiva ( $20.6M ).

Langlopende schulden: De kortetermijnactiva UPC ( $33.5M ) overtreffen de langetermijnschulden ( $2.1M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: UPC heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van UPC is de afgelopen 5 jaar gestegen van 23.3% naar 24.3%.

Schuldendekking: De operationele kasstroom van UPC is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van UPC op haar schulden goed worden gedekt door EBIT.


Balans


Ontdek gezonde bedrijven